16:09 EDT CytomX Therapeutics files $250M mixed securities shelf
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CTMX:
- CytomX Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
- CTMX Earnings this Week: How Will it Perform?
- CytomX Therapeutics to Present at the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference
- CytomX Therapeutics Appoints Chris Ogden as New CFO
- CytomX Therapeutics Promotes Chris Ogden to Chief Financial Officer